INTRODUCTION
Based on Globocan data in 2012, cervical cancer is the fourth most common malignancy worldwide after breast, colorectal, and gastric cancer, with an estimated 528,000 new cases, and almost one-third found in South -East Asian countries. Approximately 266,000 deaths from cervical cancer (7.5% of all female cancer mortality), and about 87% of cervical cancer mortality occur in developing countries. 1 nesia in 2013, and 76.68% of them presented to the health service in advanced stages. 4 In the early stages, cervical cancer has no specific or typical signs and symptoms. Therefore, every woman is advised to undergo screening for cervical cancer as early as possible, using the method of Papanicolaou (Pap) test cytologic examination. 5 Even though the effectivity of Pap test as a screening test has not been proven with a randomized test, it has been well known to effectively decrease the incidence and mortality rate of cervical cancer in developed countries. In the United States, Pap test succeeded to change cervical cancer from the leading cause of female death to an infrequent disease, decreasing the incidence by about 75% since Pap test was found 40 years ago. However, only few countries possess adequate infrastructure and human resources to perform cervical cancer screening program, leading to the high number of cervical cancer cases in some countries, especially in developing countries. 6 In Indonesia, there are more than 13,000 islands but fewer than 300 pathologists are available, with most of them centered in urban areas. Therefore a screening method is needed, which might be as effective as Pap test or liquid based cytology (LBC) but does not require evaluation of specimens.
Recently, biophysics has emerged as a new method in the diagnosis and prevention of cervical cancer. Due to its low false positive and false negative results, biophysics method is a promising screening method for cervical cancer. Truscreen is a novel optoelectronic device utilizing this method as a screening tool for the detection of precancerous cervical lesions. This real time device uses low-level electrical and optical signals to scan the cervix. The response will be measured by computer-based expert system software, which will classify the tissue response by comparing the signals with those stored in a computer database representative of the range of cervical tissue types. 7 Because this method is automated, it might be considered for use in developing countries where the pathologists are few and are not widespread throughout the area, and can even be used by nurses or midwives. 8 There have been no studies on the use of optoelectronic device in detecting precancerous cervical lesions in Indonesia. As it seems promising and does not heavily rely on the operator or pathologists, we tried to investigate its diagnostic values in detecting precancerous cervical lesions.
METHODS
We performed a diagnostic study utilizing cross sectional design. The subjects were recruited from Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia during the period of February until December 2013. Cervical cancer screening methods were performed in all subjects in the form of optoelectronic device (TruScreen, Polartechnics Limited, Sydney, Australia), liquid based cytology, and colposcopy followed by targeted biopsy. Human Papilloma Virus (HPV) DNA test was performed only on several subjects due to its high cost.
The patient presenting to the outpatient clinic of Dr. Cipto Mangunkusumo National Hospital in the period above, who desired to undergo cervical cancer screening or referred from other centers (midwives, public health care, OBGYN, general practitioner) with suspected precancerous cervical lesion were included in this study. Patients refusing to join this study, those with suspected or confirmed cervical cancer, and confirmed invasive carcinoma on biopsy were excluded.
The samples were enrolled based on consecutive sampling method until the minimum number of samples were achieved (60 samples). All patients gave their consent after being informed by the investigators.
Data were analyzed using SPSS 21.0. Abnormal results of optoelectronic device, biopsy, cytologic examination, colposcopy and HPV DNA examination will be showed descriptively. We analyzed diagnostic values for optoelectronic device, LBC, and colposcopy compared to the gold standard, anatomic pathology biopsy. To understand the similarity and comparison between two methods of cervical precancerous lesion screening, we determine the kappa value between optoelectronic device with LBC and colposcopy.
RESULTS
During the research period, 66 patients were recruited, and 6 patients were excluded due to invasive carcinoma result based on their biopsy. Subject characteristics are shown below.
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There were 32 patients (53%) with abnormalities based on the optoelectronic device, 41 patients (68,3%) with precancerous cervical lesion on biopsy, 44 patients (73,3%) with abnormal colposcopy result, and 41 patients (63,3%) with abnormal LBC result. From 41 patients who had confirmed cervical precancerous lesion on biopsy, 18 (44%) had low grade squamous intraepithelial lesion (CIN 1) and 23 (56%) had high grade squamous intraepithelial lesion (CIN 2 and 3, carcinoma in situ).
Sensitivity, specificity, positive predictive value, and negative predictive value of optoelectronic device were 76%, 95%, 96%, and 64%, respectively. We also investigated the diagnostic values of other screening methods, namely cytology and colposcopy. Sensitivity and specificity of LBC were 83% and 63%, respectively. Sensitivity and specificity of colposcopy were 88% and 58%, respectively. The combination of optoelectronic device and LBC increased the sensitivity to 92,8%.
To evaluate inter-rater agreement, we analyzed the Kappa value. Kappa value for optoelectronic device with cytology was 0.35 (fair) and for optoelectronic device with colposcopy was 0.45 (moderate). These values mean optoelectronic device is quite similar or might be comparable with cytology and colposcopy in screening of precancerous cervical lesion.
DISCUSSION
In this study, we excluded cases with confirmed cervical cancer as proven by biopsy or clinical examination, because the objective of our study is to investigate the diagnostic values of optoelectronic device in detecting cervical pre-cancerous lesion as early as possible so that the patient might be treated properly before the development of cervical cancer.
In our study, the number of abnormal optoelectronic device test results was quite high (> 50%), indicating the presence of precancerous cervical lesion, either low grade squamous intraepithelial lesion (LGSIL) or high grade squamous intraepithelial lesion (HGSIL). The sensitivity of optoelectronic device in detecting precancerous cervical lesion in our study was 76%, which was in line with the study by Lee et al. 9 They concluded that Truscreen has a sensitivity of 75.8% in detecting CIN 1 and 77.3% for CIN 2/3, with 85.1% specificity. In a multicenter study of 651 subjects by Singer et al, the sensitivity of Truscreen was reported to be 67% for CIN 1 and 70% for CIN 2/3. 7 However, Allameh and Long reported lower sensitivity; 46.9% and 67.4%, respectively. 8, 10 We observed that the sensitivity of this device in detecting LGSIL (88.24%) was higher than HGSIL (96%), in contrast to the previous study, which was 67% versus 70%. 7 Different sampling methods in both studies might be the cause of this difference. Surprisingly, we observed a high specificity for optoelectronic device, which was even higher than LBC and colposcopy. This result was supported by previous studies conducted by Lee and Lim, who reported a specificity of 85.1% and 81.4, respectively. 9, 11 Pruski et al reported the area under the ROC curve of optoelectronic device to detect HGSIL and squamous cell carcinoma was 0.88, which indicates a high diagnostic value. 12 We attempted to evaluate whether optoelectronic device was equal or more reliable in comparison to other commonly known methods of cervical cancer screening such as LBC and colposcopy. Based on inter-rater agreement analysis, kappa value for optoelectronic device with cytology was 0.35 (fair) and optoelectronic device with colposcopy was 0.45 (moderate). Therefore, we can conclude that optoelectronic device was comparable with LBC and colposcopy in detecting precancerous cervical lesion.
There are some advantages in performing optoelectronic device to detect precancerous cervical lesion, specifically in Indonesia. Automated processed result of this device will decrease the risk of human error and not having to rely on laboratory examinations, immediate results (real time examination) will reduce the number of patient visits, shortened screening-treatment timeline, reduced loss of follow-up, and finally, decreased cost in cervical cancer screening programs.
CONCLUSION
A real-time optoelectronic device might be used as an alternative method in early detection of precancerous cervical lesions, either as a single method or combined with liquid based cytology.
